Shukra [SHUKRAPHAR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Shukra
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Shukra wins in 7 metrics, Sun Pharmaceutical wins in 12 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shukra | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 83.45 | 36.65 | Sun Pharmaceutical |
| Price-to-Book Ratio | 13.11 | 5.28 | Sun Pharmaceutical |
| Debt-to-Equity Ratio | 6.65 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | N/A | 48.59 | N/A |
| EV/EBITDA | 49.17 | 23.29 | Sun Pharmaceutical |
| Profit Margin (TTM) | 26.02% | 19.29% | Shukra |
| Operating Margin (TTM) | 53.21% | 24.34% | Shukra |
| EBITDA Margin (TTM) | 53.21% | 24.34% | Shukra |
| Return on Equity | 15.90% | 15.08% | Shukra |
| Return on Assets (TTM) | 10.58% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $51.75M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | 7.26% | 1.26% | Shukra |
| 1-Year Return | 193.29% | -7.71% | Shukra |
| Price-to-Sales Ratio (TTM) | 21.85 | 7.08 | Sun Pharmaceutical |
| Enterprise Value | $8.33B | $3,572.58B | Sun Pharmaceutical |
| EV/Revenue Ratio | 22.63 | 6.64 | Sun Pharmaceutical |
| Gross Profit Margin (TTM) | 86.72% | 79.58% | Shukra |
| Revenue per Share (TTM) | $1 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $0.22 | $43.32 | Sun Pharmaceutical |
| Beta (Stock Volatility) | 0.33 | 0.31 | Sun Pharmaceutical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Shukra vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shukra | -1.98% | -9.47% | -9.78% | 51.86% | -16.36% | 28.30% |
| Sun Pharmaceutical | 1.35% | -2.02% | -3.80% | -4.61% | -5.37% | -14.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shukra | 193.29% | 295.69% | 1,717.82% | 1,019.51% | 394.88% | 394.88% |
| Sun Pharmaceutical | -7.71% | 78.44% | 202.13% | 71.49% | 797.34% | 2,678.37% |
Performance & Financial Health Analysis: Shukra vs Sun Pharmaceutical
| Metric | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹8.04B | ₹3.81T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 91,148 | 2,880,842 |
| 90 Day Avg. Volume | 190,256 | 2,133,319 |
| Last Close | ₹18.36 | ₹1,608.40 |
| 52 Week Range | ₹5.75 - ₹27.15 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -32.38% | -17.95% |
| All-Time High | ₹27.15 (Mar 03, 2025) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -32.38% | -17.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.30% | 0.10% |
| Quarterly Earnings Growth | 0.35% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.26% | 0.19% |
| Operating Margin (TTM) | 0.53% | 0.24% |
| Return on Equity (TTM) | 0.16% | 0.15% |
| Debt to Equity (MRQ) | 6.65 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.40 | ₹300.99 |
| Cash per Share (MRQ) | ₹0.27 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹79.18M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹41.04M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 7.26% | 1.26% |
| Last 12-Month Dividend | ₹1.00 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Shukra vs Sun Pharmaceutical
| Metric | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 83.45 | 36.65 |
| Forward P/E | N/A | 48.59 |
| PEG Ratio | N/A | 48.59 |
| Price to Sales (TTM) | 21.85 | 7.08 |
| Price to Book (MRQ) | 13.11 | 5.28 |
| Market Capitalization | ||
| Market Capitalization | ₹8.04B | ₹3.81T |
| Enterprise Value | ₹8.33B | ₹3.57T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.63 | 6.64 |
| Enterprise to EBITDA | 49.17 | 23.29 |
| Risk & Other Metrics | ||
| Beta | 0.33 | 0.31 |
| Book Value per Share (MRQ) | ₹1.40 | ₹300.99 |
Financial Statements Comparison: Shukra vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹132.70M | ₹137.86B |
| Cost of Goods Sold | ₹17.63M | ₹28.15B |
| Gross Profit | ₹115.07M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹63.76M | ₹33.72B |
| EBITDA | ₹87.85M | ₹47.66B |
| Pre-Tax Income | ₹75.70M | ₹31.73B |
| Income Tax | ₹21.84M | ₹8.70B |
| Net Income (Profit) | ₹53.86M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | N/A | ₹102.69B |
| Total Current Assets | ₹654.27M | ₹526.24B |
| Total Current Liabilities | ₹172.84M | ₹181.94B |
| Long-Term Debt | ₹31.13M | ₹3.58B |
| Total Shareholders Equity | ₹628.36M | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹193.97M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 91,148 | 2,880,842 |
| Average Daily Volume (90 Day) | 190,256 | 2,133,319 |
| Shares Outstanding | 437.88M | 2.40B |
| Float Shares | 47.92M | 1.04B |
| % Held by Insiders | 0.89% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Shukra vs Sun Pharmaceutical
| Metric | SHUKRAPHAR | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹21.00 |
| Last 12-Month Dividend Yield | 7.26% | 1.26% |
| 3-Year Avg Annual Dividend | ₹0.35 | ₹14.67 |
| 3-Year Avg Dividend Yield | 5.23% | 0.46% |
| 3-Year Total Dividends | ₹1.04 | ₹44.00 |
| Ex-Dividend Date | Sep 23, 2024 | Jul 07, 2025 |